Osmetech Plans to Submit Warfarin Assay to FDA by Year End | GenomeWeb
NEW YORK (GenomeWeb News) - Osmetech today said it plans to submit an assay to predict individual response to the blood-thinning drug warfarin to the US Food and Drug Administration sometime late in 2007.
 
The company said it plans to launch the warfarin test, which will run on its eSensor XT-8 molecular diagnostic platform, in the first half of 2008.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: diatom genetic diversity, microfluidic droplet method for single-cell screening, and more.

Scientific publishers are looking into whether artificial intelligence can help the peer-review process, Wired reports.

Researchers are using gene editing to develop more robust livestock and crops, AFP reports.

Researchers rally near the American Association for the Advancement of Science annual meeting in Boston.